Therapy Areas: Oncology
Anixa Biosciences adds Dr Sanjay Juneja to Cancer Business Advisory Board
19 April 2024 - Anixa Biosciences, Inc. (NASDAQ: ANIX), a California-based clinical-stage biotechnology company, announced on Thursday that it has added Sanjay Juneja, MD to its Cancer Business Adviso...
TAE Life Sciences names new director
18 April 2024 - TAE Life Sciences, a US-based company that deals with advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, announced on Wednesday that it has named Dr Deepak 'Dee&...
Circio ends TG01 cancer vaccine licence deal with IOVaxis in China
17 April 2024 - Circio Holding ASA (OSE:CRNA), a biotechnology company developing next generation circular RNA vector technology for gene therapy and cancer vaccines, revealed on Wednesday that it has...
BiVictriX receives FDA Orphan Drug Designation for AML treatment candidate
17 April 2024 - Biotechnology company BiVictriX Therapeutics plc (AIM: BVX) announced on Wednesday that it has received FDA Orphan Drug Designation (ODD) for BVX001 in Acute Myeloid Leukaemia (AML) tr...
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
17 April 2024 - Germany-based pharmaceutical company Boehringer Ingelheim announced on Tuesday a strong acceleration of its pipeline in 2023, as pivotal trials in key research areas progressed as plan...
AstraZeneca reveals Imfinzi plus chemotherapy Phase III trial results in patients with advanced biliary tract cancer
17 April 2024 - UK-based pharmaceutical company AstraZeneca announced on Tuesday that updated exploratory results from the TOPAZ-1 Phase III trial showed that AstraZeneca's Imfinzi (durvalumab) i...